P1-IS-32 Targeted Alpha Therapy for Ovarian Cancer : Development and Characterization of Bismuth-213 (213 Bi) labeled uPAR-selective Radioligands
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI